19 March 2010

Optos

SPECULATIVE BUY

21/07/2006 Adam Wayland

Fully-listed retinal screening technology specialist Optos, established after founder Douglas Anderson’s five-year-old son went blind in one eye when a retinal detachment was detected too late, now counts over 8m retinal exams using its innovative imaging device – up 40% from the first half of 2005.

Optos’ ‘unique non-invasive imager’, captures a high-resolution digital image of the retina. While routine examination methods provide only a limited, narrow-field view - typically less than 5% in a single capture – its new scan captures over 80% of the retina in a mere quarter of a second.

The company believes this ‘optomap’ device will significantly reduce the risk of missing early signs of eye diseases as well as highlighting other non-eye related diseases such as diabetes, hypertension and certain cancers.

The technology is leased on three-year agreements, and each use incurs a charge subject to a minimum monthly amount. At present Optos boasts a 90% renewal rate of leases for its devices, of which there are over 2000 installed (up 39.7% from the first half of 2005).

Interims to March revealed near 44% growth in revenues to £16.9m, of which 96% arose in the US and 4% from Europe. Entry into the French and Spanish market is targeted for the next 12 months, with Japan also on the radar, although a lengthy regulatory process could mean that this is 20 months away.

Floated in February at 250p, the shares have suffered recently, perhaps due to perceived difficulties in breaking into the UK market, although studies are currently underway by an NHS trust to test the suitability of the device. Optos is currently trading at 197p – valuing the company at £129.6m – well south of the 285p targeted by brokers.

House broker Goldman Sachs regards Optos as a ’compelling long-term growth stock’ and expects the shares to 'outperform'. Analysts tip Optos to break even in the second half and become profitable in 2007 to the tune of £2m at the pre-tax line. The shares are certainly appealing.

Sector: Health Care Equipment & Services

Companies: Optos

Market cap: £129.6m

PE Forecast: 10.9

Share price: 197p

Subscribe today

£7,277

That’s what you would have in your portfolio if you had invested £6,000 into the six Company Watch recommendations in our April 2009 issue.

Subscribe now and receive a 50% discount

AIM in Review 2010

Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.

M&A on AIM 2009 - Which are the most active sectors for M&A? Which are the most active brokers to follow?

M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.

Free – Latest Stock Recommendations

Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.

Select your level of risk and we select the funds

Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.

The AIM Guide 2009/10

The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies.   Order your copy today and benefit from a £10 discount!

VCT Special Report 2009

This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.

Cash Shells Special Report 2009

Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.

Share recommendations and small-cap stock picks

Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.

Popular Recommendations

Latest Recommendations

KBC Advanced Technologies 19/03/2010

Energy industry consultant KBC performed resiliently in recession-hit 2009 and entered 2010 with a robust order book.

TEG Group 19/03/2010

Organic composting specialist TEG is pursuing long-term contracts after turning £1.6m of annual losses into £155,000 pre-tax profits in calendar 2009.

European Goldfields 18/03/2010

European Goldfields hopes to move from AIM to the Full List by the end of 2010 after securing a key permit in Romania.

More Recommendations

Sectors

Vitesse Media Events